Stockreport
Chinese Biotech Is the Future [The Motley Fool]
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
Chinese Biotech Is the Future In this week's episode of Industry Focus: Healthcare Loncar Investments Tune in to learn what shifts have radically changed this space in just the last year, how regulators and government play into the picture, some lower-risk ways to get exposure to this admittedly very volatile market, and why investors definitely shouldn't ignore this for the long term. A full transcript follows the video. This video was recorded on March , 09. Shannon Jones: In this interview, Brad shares with us his thoughts about investing in China from a regulatory front, the trends he's keeping an eye on, and where he sees the biggest opportunities for investors. We hope you enjoy this conversation just as much as we did. [...] Simon Erickson: Brad, thanks so much for joining us! Brad Loncar: For purposes of time, I won't go into too much depth, but there's three or four things that are making that happen. The Chinese government is supporting it and investing in it. They want to s
[Read more]
IMPACT SNAPSHOT | EVENT TIME: | AMGN | ||||
---|---|---|---|---|---|---|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
LAST PRICE | ||
VWAP | ||
High:
|
MAX UP |
High:
|
Low:
|
MAX DOWN |
Low:
|
%
|
POST NEWS RANGE |
%
|
|
PRICE CHANGE |
|
|
PRICE CHANGE PERCENTAGE |
|
|
S&P 500 (SPX) |
|
%
|
VOLUME RATIO |
%
|
VOLUME (SHARES) | ||
TICKS | ||
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
AMGN alerts
AMGN alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
NEWS
NEWS
- Biologic Therapeutics Drugs Market Size Projections Exhibit a CAGR of 12.2%%, Likely to Attain a Value of USD 1485.0 Billion by 2033 [Yahoo! Finance][Yahoo! Finance]
- Microbial Products Market to Gain $286.53 Billion, by 2033 with 6% CAGR: States The Brainy Insights [Yahoo! Finance][Yahoo! Finance]
- Why Amgen (AMGN) Outpaced the Stock Market Today [Yahoo! Finance][Yahoo! Finance]
- 3 Generic Drug Stocks to Watch Amid Challenging Market Prospects [Yahoo! Finance][Yahoo! Finance]
- Amgen Inc. (NASDAQ: AMGN) had its price target lowered by analysts at UBS Group AG from $314.00 to $284.00. They now have a "neutral" rating on the stock.[MarketBeat]
- More
AMGN
SEC Filings
SEC Filings
- 4/17/24 - Form DEFA14A
- 4/17/24 - Form DEF
- 4/10/24 - Form ARS
- AMGN's page on the SEC website
- More